Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IntensVIH: Therapy Intensification in HIV-1
NCT00935480Phase 3Completed
- Sponsor
- Centre Hospitalier Intercommunal de Toulon-La Seyne-sur-Mer
- Start
- Oct 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir, maraviroc in human immunodeficiency virus infection (HIV), sponsored by Centre Hospitalier Intercommunal de Toulon-La Seyne-sur-Mer. Started Oct 2010; status: completed.
02
Drugs
raltegravirmaraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00935480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00935480.